Davide Stolfo
Overview
Explore the profile of Davide Stolfo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
1885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savonitto G, Paldino A, Setti M, Berra A, Radesich C, Perotto M, et al.
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39999024
Aims: While the exacerbating effect of physical exercise and its correlation with arrhythmic outcomes have been demonstrated for Arrhythmogenic Right Ventricular Cardiomyopathy, the impact of physical exercise on other forms...
2.
Pagura L, Fabris E, Rakar S, Gabrielli M, Mazzaro E, Sinagra G, et al.
J Crit Care
. 2025 Feb;
87:155037.
PMID: 39961168
No abstract available.
3.
Gigli M, Stolfo D, Barbati G, Graw S, Chen S, Merlo M, et al.
JAMA Cardiol
. 2025 Feb;
PMID: 39937464
Importance: Filamin C truncating variants (FLNCtv) are a rare cause of cardiomyopathy with heterogeneous phenotypic presentations. Despite a high incidence of life-threatening ventricular arrhythmias and sudden cardiac death (SCD), reliable...
4.
5.
Chiarito M, Stolfo D, Villaschi A, Sartori S, Baldetti L, Lombardi C, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39834041
Aims: Accurate selection of patients with severe heart failure (HF) who might benefit from advanced therapies is crucial. The present study investigates the performance of the available risk scores aimed...
6.
Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor M, Mestroni L
Nat Rev Cardiol
. 2024 Oct;
22(3):183-198.
PMID: 39394525
Dilated cardiomyopathy (DCM) is a complex disease with multiple causes and various pathogenic mechanisms. Despite improvements in the prognosis of patients with DCM in the past decade, this condition remains...
7.
Cocianni D, Perotto M, Barbisan D, Contessi S, Rizzi J, Savonitto G, et al.
J Cardiovasc Med (Hagerstown)
. 2024 Sep;
25(11):789-798.
PMID: 39347727
Aims: Secondary mitral regurgitation (MR) negatively affects prognosis in acutely decompensated heart failure (ADHF), but can be rapidly sensitive to changes in volume status and medical interventions. We sought to...
8.
Manzi G, Benza R, Argiento P, Casu G, Corda M, Correale M, et al.
Vascul Pharmacol
. 2024 Sep;
157:107432.
PMID: 39265796
Despite the innovations introduced in the 2022 European Society of Cardiology/European Respiratory Society Guidelines on Pulmonary Hypertension, risk discrimination and management of pulmonary arterial hypertension (PAH) patients at intermediate risk...
9.
Zocca E, Cocianni D, Barbisan D, Perotto M, Contessi S, Rizzi J, et al.
Eur J Heart Fail
. 2024 Aug;
26(11):2367-2378.
PMID: 39192688
Aims: Secondary tricuspid regurgitation (TR) is associated with poor prognosis in acute decompensated heart failure (ADHF). However, its dynamic evolution in response to volume status and treatment has never been...
10.
Stolfo D, Benson L, Lindberg F, Dahlstrom U, Kack O, Sinagra G, et al.
Eur J Heart Fail
. 2024 Jul;
26(10):2243-2257.
PMID: 39078343
Aims: We explored timing, settings and predictors of angiotensin receptor-neprilysin inhibitor (ARNI) initiation in a large, nationwide cohort of patients with heart failure (HF) with reduced ejection fraction (HFrEF). Methods...